Announcement on Withdrawal of Drug Registration Application by Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 2 pages · Chinese
Beijing Tiantan Biological Products Corporation Limited announced the withdrawal of a drug registration application by its subsidiary, Chengdu Rongseng Pharmaceutical Co., Ltd., for a specific recombinant coagulation factor product. The withdrawal was prompted by the need for additional clinical trial data for pediatric patients as per the review comments from the drug regulatory authority. The company plans to resubmit the application after completing the necessary clinical data work.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Announcement on Withdrawal of Drug Registration Application by Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Beijing Tiantan Biological Products Corporation Limited on 6ix
Follow Beijing Tiantan Biological Products into a list and get an email when it puts out news.
Follow Beijing Tiantan Biological Products